XML 14 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 10 Months Ended 12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2016
Jun. 30, 2018
Jun. 30, 2017
Oct. 26, 2016
Dec. 31, 2017
Operating expenses:              
General and administrative $ 946,685 $ 731,973   $ 1,939,120 $ 1,175,990    
Research and development 225,529 156,716   330,574 228,757    
Total operating expenses 1,172,214 888,689   2,269,694 1,404,747    
Loss from operations (1,172,214) (888,689)   (2,269,694) (1,404,747)    
Interest expense (304,403) (350,049)   (497,437) (563,599)    
Net change in fair value for the warrant liability and premium conversion derivatives 215,631 (55,585)   335,591 (55,553)    
Loss on convertible notes and short-term notes extinguishment, net   (186,220)    
Net loss $ (1,260,986) $ (1,294,323)   $ (2,617,760) $ (2,023,899)    
Net loss per share:              
Basic and diluted $ (0.16) $ (0.22)   $ (0.33) $ (0.37)    
Number of shares used in per share calculations:              
Basic and diluted 7,967,741 5,868,995   7,916,651 5,544,582    
NeuroOne LLC              
Operating expenses:              
General and administrative           $ 6,657  
Research and development            
Total operating expenses           6,657  
Loss from operations           (6,657)  
Interest expense           (11,947)  
Loss on convertible notes and short-term notes extinguishment, net            
Net loss           $ (18,604)  
Successor              
Operating expenses:              
General and administrative     $ 182,667       $ 2,336,988
Research and development           735,333
Total operating expenses     182,667       3,072,321
Loss from operations     (182,667)       (3,072,321)
Interest expense     (83,297)       (1,395,138)
Net change in fair value for the warrant liability and premium conversion derivatives     (406)       (240,053)
Loss on convertible notes and short-term notes extinguishment, net           (350,914)
Net loss     $ (266,370)       $ (5,058,426)
Net loss per share:              
Basic and diluted     $ (0.06)       $ (0.77)
Number of shares used in per share calculations:              
Basic and diluted     4,421,092       6,610,072